1. Home
  2. INLF vs ISPC Comparison

INLF vs ISPC Comparison

Compare INLF & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INLF

INLIF LIMITED

HOLD

Current Price

$2.78

Market Cap

3.5M

Sector

Industrials

ML Signal

HOLD

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

HOLD

Current Price

$1.08

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLF
ISPC
Founded
2016
2009
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Precision Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
4.0M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
INLF
ISPC
Price
$2.78
$1.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.0M
129.2K
Earning Date
09-24-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.03
EPS
★ N/A
N/A
Revenue
N/A
★ $1,928,998.00
Revenue This Year
N/A
$638.10
Revenue Next Year
N/A
$17.50
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.02
$1.02
52 Week High
$9.91
$115.00

Technical Indicators

Market Signals
Indicator
INLF
ISPC
Relative Strength Index (RSI) 40.11 31.46
Support Level $2.38 $1.02
Resistance Level $4.92 $1.94
Average True Range (ATR) 0.54 0.08
MACD -0.08 0.02
Stochastic Oscillator 0.65 19.35

Price Performance

Historical Comparison
INLF
ISPC

About INLF INLIF LIMITED

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

Share on Social Networks: